April 2020 – Page 2 – Policy & Medicine

FDA Eases Some Requirements in the COVID-19 Fight

DEA Allows Controlled Substance Prescriptions to Be Issued Via Telemedicine

Sanofi Doesn’t Expect Drug Shortages Related to COVID-19

DOJ, FDA and HHS Sound the Alarm About COVID-19 Fraud Schemes

HHS Allows Pharmacists to Order and Administer COVID-19 Tests

White House Analysis on Drug Prices Highlights R&D Investments and Rising Drug Prices

HHS ONC Releases Final Rule Implementing the Cures Act

COVID-19 HHS and FCC Telehealth Changes

Does Pharma Hold the Key to a COVID-19 Solution?

Former Sandoz/Novartis AG Executive Pleads Guilty to Price Fixing